CELLULAR-DISTRIBUTION OF NICOTINIC ACETYLCHOLINE-RECEPTOR SUBUNIT MESSENGER-RNAS IN THE HUMAN CEREBRAL-CORTEX AS REVEALED BY NONISOTOPIC IN-SITU HYBRIDIZATION

Citation
A. Wevers et al., CELLULAR-DISTRIBUTION OF NICOTINIC ACETYLCHOLINE-RECEPTOR SUBUNIT MESSENGER-RNAS IN THE HUMAN CEREBRAL-CORTEX AS REVEALED BY NONISOTOPIC IN-SITU HYBRIDIZATION, Molecular brain research, 25(1-2), 1994, pp. 122-128
Citations number
26
Categorie Soggetti
Neurosciences
Journal title
ISSN journal
0169328X
Volume
25
Issue
1-2
Year of publication
1994
Pages
122 - 128
Database
ISI
SICI code
0169-328X(1994)25:1-2<122:CONASM>2.0.ZU;2-V
Abstract
The pharmacology of telencephalic nicotinic acetylcholine receptors (n AChRs) has become an important issue in recent years. While in the hum an brain a direct pharmacological assessment is difficult to achieve t he visualization of nAChRs has been enabled by histochemical technique s providing an ever increasing and improving resolution. Receptor auto radiography was used to visualize binding sites on the level of cortic al layers whereas immunohistochemistry has allowed for the cell type-s pecific and ultrastructural localization of receptor protein. Further investigations have to elucidate the cellular sites of nAChR biosynthe sis by visualizing subunit-specific transcripts. Using autopsy samples of the human precentral cortex (Area 4) as a paradigm we have applied digoxigenin-labeled cRNA probes to localize transcripts for the alpha 3- and alpha 4-1-subunits of the nAChR. In accordance with findings i n the monkey cortex, the alpha 3-subunit seems to be expressed mainly in pyramidal neurons of layers III-VI of the human cerebral cortex. Tr anscripts for the alpha 4-1-subunit, by contrast, appear to be present in a large number of neurons throughout all layers of the cerebral co rtex, consonant with its ubiquitous distribution in the rodent brain. The present findings show that also in human autopsy brains the cell t ype-specific detection of nAChR transcripts is possible. For the futur e, this technique will enable to investigate the expression of recepto r transcripts in diseased human brains as compared to controls.